SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-23-001285
Filing Date
2023-07-10
Accepted
2023-07-10 17:24:47
Documents
13
Period of Report
2023-07-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e4857_8k.htm   iXBRL 8-K 29707
2 EXHIBIT 3.1 e4857_ex3-1.htm EX-3.1 48128
  Complete submission text file 0001731122-23-001285.txt   265827

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enob-20230707.xsd EX-101.SCH 3024
4 XBRL LABEL FILE enob-20230707_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE enob-20230707_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT e4857_8k_htm.xml XML 3432
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 231080628
SIC: 2834 Pharmaceutical Preparations